Master of Science in Pharmaceutical Science (MSP), University of Toledo, 2020, Pharmaceutical Sciences (Pharmacology/Toxicology)
In response to legal restrictions on methamphetamine (MA) and 3,4- methylenedioxymethamphetamine (MDMA), there has been an increase in the use of synthetic psychoactive cathinone's (SPCs). SPCs are structurally similar to MA and MDMA, sharing many of their psychostimulant properties, however, there is some question as to whether the drugs in this class share similar hyperthermic, lethal, and neurotoxic effects as MA and MDMA. While the mechanisms of action of these drugs are still being studied, clinical reports suggest that they produce hepatocellular damage, contributing to their potential lethal effects. In studies in mice and zebrafish, the Hall laboratory has shown that MA, MDMA and SPCs induce lethal effects that are associated with seizures, perhaps indicative of uncontrolled glutamatergic activation. In a series of experiments, Halpin and Yamamoto (Halpin et al., 2013; Halpin and Yamamoto, 2012) have shown that MA induces liver impairments and elevations in plasma ammonia that contribute to increased glutamatergic activity. In our own studies we have also observed that liver tissue was severely damaged by exposure to these drugs, encouraging the use of liver cells to further understand how these drugs work. In the following project different concentrations of MA and MDMA were used in order to determine the IC50 values and the mechanism of cell death. The obtained IC50 values of MA and MDMA, through MTT assay, were used to define dose ranges for subsequent studies: a concentration which would not cause any cell death (0 mM), a concentration which is below our observed IC50 (1 mM), a concentration just above the observed IC50 values (3 mM), and a concentration which would almost completely inhibit cell survival (10 mM). In order to determine the mechanism of cell death, this study included MTT assays, LDH assays, ROS assays, and Western blots, as well as data obtained through the Incucyte live cell imaging system. MTT assays determine the concentration of drug (open full item for complete abstract)
Committee: Scott Hall (Committee Chair); Terry Hinds (Committee Member); Amit Tiwari (Committee Member)
Subjects: Biology; Cellular Biology; Experiments; Health Sciences; Morphology; Pharmaceuticals; Pharmacology; Pharmacy Sciences; Toxicology